Dark

APGNW
Apexigen, Inc. WarrantApexigen, Inc. Warrant
stock NASDAQ

Inactive

Aug 22, 2023

0.0261USD+30.650%(+0.0061)3,130

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-0.02)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsTrends

open chart

Industry

Research and Development in Biotechnology

Profile

apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by apximab™, the company's proprietary antibody drug discovery platform. its lead immuno-oncology drug candidate, apx005m, is a potent immune-activating antibody against cd40 currently in phase 2 clinical development.

.dark-mode .YJGr9y{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .YJGr9y{ color: #333333; background-color: white; border: 2px solid #333333; }APGNWApexigen, Inc. WarrantApexigen, Inc. Warrantstock NASDAQ

APGNW
Apexigen, Inc. WarrantApexigen, Inc. Warrant
stock NASDAQ